Viewing Study NCT03206151


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-02-11 @ 6:58 AM
Study NCT ID: NCT03206151
Status: COMPLETED
Last Update Posted: 2025-05-23
First Post: 2017-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module